"image Description" (Spl Carton Label Bumetanide)
Bumetanide Injection, Solution
Product Images NDC 83854-007
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Bumetanide (NDC 83854-007). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Anthea Pharma Private Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
"image Description" (Spl Container Label Bumetanide)
This is a description of Bumetanide Injection, a medication administered intravenously or intramuscularly. Each 4mL single-dose vial contains 0.25 mg of bumetanide, sodium chloride, ammonium acetate, edetate disodium dihydrate, and benzyl alcohol as a preservative. The solution is adjusted to a pH of 6.8-7.8 with sodium hydroxide and should be stored at 20°C to 25°C. It is important to discard any unused portion. The manufacturer of this medication is AntheaPharma Private Limited in Hyderabad, India. It is crucial to protect the medication from light.*
"image Description" (Spl Structure Bumetanide)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
